Literature DB >> 21429077

Recurrence risk of hyperemesis gravidarum.

Marlena S Fejzo1, Kimber W Macgibbon, Roberto Romero, T Murphy Goodwin, Patrick M Mullin.   

Abstract

INTRODUCTION: The purpose of this study is to describe the recurrence risk for hyperemesis gravidarum (HG).
METHODS: Women who registered on a Web site sponsored by the Hyperemesis Education and Research Foundation as having had one HG-complicated pregnancy were contacted to follow-up on a subsequent pregnancy. Participants completed an online survey.
RESULTS: One hundred women responded. Fifty-seven had become pregnant again, 2 were trying to conceive, 37 were not willing to get pregnant again because of HG, and 4 did not have a second pregnancy for other reasons. Among the 57 women who responded that they had become pregnant again, 81% reported having severe nausea and vomiting in their second pregnancy. Among the women reporting recurrent HG, 98% reported losing weight and taking prescribed medication for HG, 83% reported treatment with intravenous fluids, 20% reported treatment with total parenteral nutrition or nasogastric tube feeding, and 48% reported hospitalization for HG. DISCUSSION: This study demonstrates both a high recurrence rate of HG and a large percentage of women who change reproductive plans because of their experiences with HG.
© 2011 by the American College of Nurse-Midwives.

Entities:  

Mesh:

Year:  2011        PMID: 21429077      PMCID: PMC3077880          DOI: 10.1111/j.1542-2011.2010.00019.x

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  22 in total

Review 1.  A case of spontaneous ovarian hyperstimulation syndrome with a potential mutation in the hCG/LH receptor gene.

Authors:  F M Akerman; Z Lei; C V Rao; S T Nakajima
Journal:  Fertil Steril       Date:  2000-08       Impact factor: 7.329

2.  Food rejection by female rhesus monkeys during the menstrual cycle and early pregnancy.

Authors:  J A Czaja
Journal:  Physiol Behav       Date:  1975-05

3.  Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy.

Authors:  A M Innes; L E Seargeant; K Balachandra; C R Roe; R J Wanders; J P Ruiter; O Casiro; D A Grewar; C R Greenberg
Journal:  Pediatr Res       Date:  2000-01       Impact factor: 3.756

Review 4.  Nausea and vomiting in pregnancy.

Authors:  D V Fairweather
Journal:  Am J Obstet Gynecol       Date:  1968-09-01       Impact factor: 8.661

Review 5.  Supertasting, earaches and head injury: genetics and pathology alter our taste worlds.

Authors:  L M Bartoshuk; V B Duffy; D Reed; A Williams
Journal:  Neurosci Biobehav Rev       Date:  1996       Impact factor: 8.989

Review 6.  Abnormal stimulation of the thyrotrophin receptor during gestation.

Authors:  Patrice Rodien; Nicola Jordan; Anne Lefèvre; Julien Royer; Claudine Vasseur; Frédérique Savagner; Aline Bourdelot; Vincent Rohmer
Journal:  Hum Reprod Update       Date:  2004 Mar-Apr       Impact factor: 15.610

7.  Hospitalizations during pregnancy among managed care enrollees.

Authors:  Julie A Gazmararian; Ruth Petersen; Denise J Jamieson; Laura Schild; Melissa M Adams; Anjali D Deshpande; Adele L Franks
Journal:  Obstet Gynecol       Date:  2002-07       Impact factor: 7.661

8.  Severe vomiting during pregnancy: antenatal correlates and fetal outcomes.

Authors:  J Zhang; W W Cai
Journal:  Epidemiology       Date:  1991-11       Impact factor: 4.822

9.  Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum.

Authors:  Marlena S Fejzo; Borzouyeh Poursharif; Lisa M Korst; Shari Munch; Kimber W MacGibbon; Roberto Romero; T Murphy Goodwin
Journal:  J Womens Health (Larchmt)       Date:  2009-12       Impact factor: 2.681

10.  The epidemiology of pregnancy complications and outcome in a Norwegian twin population.

Authors:  L A Corey; K Berg; M H Solaas; W E Nance
Journal:  Obstet Gynecol       Date:  1992-12       Impact factor: 7.661

View more
  6 in total

Review 1.  Treatment options for hyperemesis gravidarum.

Authors:  Amy Abramowitz; Emily S Miller; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2017-01-09       Impact factor: 3.633

2.  Hyperemesis Gravidarum: Risk of Recurrence in Subsequent Pregnancies.

Authors:  Michael J Fassett; Morgan R Peltier; Adrian H Lopez; Vicki Y Chiu; Darios Getahun
Journal:  Reprod Sci       Date:  2022-09-26       Impact factor: 2.924

Review 3.  Barriers and Challenges in Hyperemesis Gravidarum Research.

Authors:  Iris J Grooten; Tessa J Roseboom; Rebecca C Painter
Journal:  Nutr Metab Insights       Date:  2016-02-14

Review 4.  The chance of recurrence of hyperemesis gravidarum: A systematic review.

Authors:  Caitlin R Dean; Claartje M Bruin; Margaret E O'Hara; Tessa J Roseboom; Mariska M Leeflang; René Spijker; Rebecca C Painter
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-12-20

5.  Antiemetic Prescription Fills in Pregnancy: A Drug Utilization Study Among 762,437 Pregnancies in Norway.

Authors:  Marleen M H J van Gelder; Hedvig Nordeng
Journal:  Clin Epidemiol       Date:  2021-02-26       Impact factor: 4.790

Review 6.  The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.

Authors:  Svetlana Madjunkova; Caroline Maltepe; Gideon Koren
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.